These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 15868740)

  • 1. Reverse 'see-saw' relationship between Graves' disease and myasthenia gravis; clinical and immunological studies.
    Sekiguchi Y; Hara Y; Takahashi M; Hirata Y
    J Med Dent Sci; 2005 Mar; 52(1):43-50. PubMed ID: 15868740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-AChR-negative myasthenia gravis: clinical and immunological features.
    Evoli A; Bartoccioni E; Batocchi AP; Scuderi F; Tonali P
    Clin Invest Med; 1989 Apr; 12(2):104-9. PubMed ID: 2706833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features of patients with myasthenia gravis associated with autoimmune diseases.
    Kanazawa M; Shimohata T; Tanaka K; Nishizawa M
    Eur J Neurol; 2007 Dec; 14(12):1403-4. PubMed ID: 17941854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding, stimulating and blocking TSH receptor antibodies to the thyrotropin receptor as predictors of relapse of Graves' disease after withdrawal of antithyroid treatment.
    Quadbeck B; Hoermann R; Hahn S; Roggenbuck U; Mann K; Janssen OE
    Horm Metab Res; 2005 Dec; 37(12):745-50. PubMed ID: 16372228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diseases caused by antibodies to receptors.
    Flier J
    Clin Immunol Rev; 1981-1982; 1(2):215-56. PubMed ID: 6299639
    [No Abstract]   [Full Text] [Related]  

  • 6. Myasthenia gravis associated with Graves' disease in Japan.
    Ohno M; Hamada N; Yamakawa J; Noh J; Morii H; Ito K
    Jpn J Med; 1987 Feb; 26(1):2-6. PubMed ID: 3573405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relevance of TSH receptor stimulating and blocking autoantibody measurement for the prediction of relapse in Graves' disease.
    Schott M; Minich WB; Willenberg HS; Papewalis C; Seissler J; Feldkamp J; Bergmann A; Scherbaum WA; Morgenthaler NG
    Horm Metab Res; 2005 Dec; 37(12):741-4. PubMed ID: 16372227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular myasthenia gravis associated with euthyroid ophthalmopathy.
    Kusuhara T; Nakajima M; Imamura A
    Muscle Nerve; 2003 Dec; 28(6):764-6. PubMed ID: 14639594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A CD40 Kozak sequence polymorphism and susceptibility to antibody-mediated autoimmune conditions: the role of CD40 tissue-specific expression.
    Jacobson EM; Huber AK; Akeno N; Sivak M; Li CW; Concepcion E; Ho K; Tomer Y
    Genes Immun; 2007 Apr; 8(3):205-14. PubMed ID: 17344890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Spontaneous hypothyroidism in 4 patients with Graves-Basedow disease].
    González-González A; Recio Cordova JM; Aznar Ondoño I; Del Monte Jarabo Bueno M
    Endocrinol Nutr; 2009 May; 56(5):273-6. PubMed ID: 19627750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetylcholine receptor antibodies in patients with Graves' ophthalmopathy.
    Jacobson DM
    J Neuroophthalmol; 1995 Sep; 15(3):166-70. PubMed ID: 8574362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classification of myasthenia gravis based on autoantibody status.
    Suzuki S; Utsugisawa K; Nagane Y; Satoh T; Terayama Y; Suzuki N; Kuwana M
    Arch Neurol; 2007 Aug; 64(8):1121-4. PubMed ID: 17698702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA, anti-DNA, and complement in myasthenia gravis.
    Christiansen FT; Houliston JB; Dawkins RL
    Muscle Nerve; 1978; 1(6):467-70. PubMed ID: 757869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some clinico-immunological aspects in patients with ocular myasthenia gravis associated with inflammatory bowel disease.
    Cojocaru IM; Cojocaru M; Tănăsescu R; Burcin C; Atanasiu AN; Mitu AC; Iliescu I; Dumitrescu L
    Rom J Intern Med; 2008; 46(2):165-8. PubMed ID: 19284089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seronegative myasthenia gravis and Graves' disease. Is there a link?
    Polymeris A; Karoutsou E; Doumouchtsis K
    Exp Clin Endocrinol Diabetes; 2012 May; 120(5):254-6. PubMed ID: 22421982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological and molecular studies of HLA in Sardinian patients with Graves' disease.
    La Nasa G; Martino E; Carcassi C; Mulargia M; Floris L; Vacca A; Baldini G; Orrù S; Ledda A; Grasso L
    Dis Markers; 1991; 9(6):307-12. PubMed ID: 1823309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial myasthenia gravis: a study of three families.
    Chin D; Gubbay SS
    Clin Exp Neurol; 1985; 21():141-8. PubMed ID: 3843213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of cellular immune responses to thyrocyte membrane antigens and specific immunoregulatory defects in autoimmune thyroid disease.
    O'Brien CJ; Macchia E; Cundy TF; Concetti R; McSorley CG; MacFarlane IG; Vento S; Eddleston AL
    J Clin Lab Immunol; 1990 Jul; 32(3):103-8. PubMed ID: 1966945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antireceptor or antihormone autoimmunity and its relationship with the idiotype network.
    Bach JF
    Adv Nephrol Necker Hosp; 1987; 16():251-80. PubMed ID: 3028089
    [No Abstract]   [Full Text] [Related]  

  • 20. Postthymectomy myasthenia gravis: relationship with thymoma and antiacetylcholine receptor antibody.
    Nakajima J; Murakawa T; Fukami T; Sano A; Takamoto S; Ohtsu H
    Ann Thorac Surg; 2008 Sep; 86(3):941-5. PubMed ID: 18721587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.